100 related articles for article (PubMed ID: 3931649)
1. Uptake in vitro of lipophilic model compounds into adipose tissue preparations and lipids.
Di Francesco C; Bickel MH
Biochem Pharmacol; 1985 Oct; 34(20):3683-8. PubMed ID: 3931649
[TBL] [Abstract][Full Text] [Related]
2. Uptake of lipophilic model compounds into the isolated perfused rat epididymal adipose tissue.
Gubser R; Di Francesco C; Bickel MH
J Pharmacol Exp Ther; 1986 Jun; 237(3):967-71. PubMed ID: 3086542
[TBL] [Abstract][Full Text] [Related]
3. Comparative adipose tissue kinetics of thiopental, DDE and 2,4,5,2',4',5'-hexachlorobiphenyl in the rat.
Mühlebach S; Wyss PA; Bickel MH
Xenobiotica; 1985 Jun; 15(6):485-91. PubMed ID: 3929482
[TBL] [Abstract][Full Text] [Related]
4. Distribution of chlorpromazine and imipramine in adipose and other tissues of rats.
Bickel MH; Graber BE; Moor M
Life Sci; 1983 Nov; 33(20):2025-31. PubMed ID: 6645788
[TBL] [Abstract][Full Text] [Related]
5. The role of adipose tissue in the distribution and storage of drugs.
Bickel MH
Prog Drug Res; 1984; 28():273-303. PubMed ID: 6435172
[No Abstract] [Full Text] [Related]
6. Differences in adipose tissue distribution of basic lipophilic drugs between intraperitoneal and other routes of administration.
Betschart HR; Jondorf WR; Bickel MH
Xenobiotica; 1988 Jan; 18(1):113-21. PubMed ID: 3354228
[TBL] [Abstract][Full Text] [Related]
7. The use of 2,4,5,2',4',5'-hexachlorobiphenyl (6-CB) as an unmetabolizable lipophilic model compound.
Mühlebach S; Wyss PA; Bickel MH
Pharmacol Toxicol; 1991 Dec; 69(6):410-5. PubMed ID: 1766915
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. I. Effects of restricting food intake two weeks after administration of 6-CB.
Wyss PA; Mühlebach S; Bickel MH
Drug Metab Dispos; 1982; 10(6):657-61. PubMed ID: 6130918
[TBL] [Abstract][Full Text] [Related]
9. Tissue distribution and half-lives of individual polychlorinated biphenyls and serum levels of 4-hydroxy-2,3,3',4',5-pentachlorobiphenyl in the rat.
Oberg M; Sjödin A; Casabona H; Nordgren I; Klasson-Wehler E; Håkansson H
Toxicol Sci; 2002 Dec; 70(2):171-82. PubMed ID: 12441362
[TBL] [Abstract][Full Text] [Related]
10. Disposition of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with decreasing adipose tissue mass. II. Effects of restricting food intake before and after 6-CB administration.
Jondorf WR; Wyss PA; Mühlebach S; Bickel MH
Drug Metab Dispos; 1983; 11(6):597-601. PubMed ID: 6140146
[TBL] [Abstract][Full Text] [Related]
11. Partitioning of polychlorinated biphenyls into human cells and adipose tissues: evaluation of octanol, triolein, and liposomes as surrogates.
Quinn CL; van der Heijden SA; Wania F; Jonker MT
Environ Sci Technol; 2014 May; 48(10):5920-8. PubMed ID: 24806981
[TBL] [Abstract][Full Text] [Related]
12. Long-term pharmacokinetics of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with constant adipose tissue mass.
Wyss PA; Mühlebach S; Bickel MH
Drug Metab Dispos; 1986; 14(3):361-5. PubMed ID: 2872039
[TBL] [Abstract][Full Text] [Related]
13. Potential mechanisms for redistribution of polychlorinated biphenyls during pregnancy and lactation.
Gallenberg LA; Vodicnik MJ
Xenobiotica; 1987 Mar; 17(3):299-310. PubMed ID: 3107224
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics in rats of 2,4,5,2',4',5'-hexachlorobiphenyl, an unmetabolizable lipophilic model compound.
Mühlebach S; Bickel MH
Xenobiotica; 1981 Apr; 11(4):249-57. PubMed ID: 6795836
[TBL] [Abstract][Full Text] [Related]
15. Influence of lipolysis on the mobilization of 2,4,5,2'4',5'-hexachlorobiphenyl from adipocytes in vitro.
Gallenberg LA; Ring BJ; Vodicnik MJ
J Toxicol Environ Health; 1987; 20(1-2):163-71. PubMed ID: 3100817
[TBL] [Abstract][Full Text] [Related]
16. Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls.
Parham FM; Kohn MC; Matthews HB; DeRosa C; Portier CJ
Toxicol Appl Pharmacol; 1997 Jun; 144(2):340-7. PubMed ID: 9194418
[TBL] [Abstract][Full Text] [Related]
17. Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs.
Ishizaki J; Yokogawa K; Ichimura F; Ohkuma S
J Pharmacol Exp Ther; 2000 Sep; 294(3):1088-98. PubMed ID: 10945864
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic study of the localization of 2,2', 4,4', 5,5'-hexachlorobiphenyl in liver and skin tissue after in vitro uptake.
Di Francesco C; Gerber HA; Bickel MH
Eur J Drug Metab Pharmacokinet; 1988; 13(4):241-5. PubMed ID: 3149587
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of distribution and elimination of DDE in rats.
Mühlebach S; Moor MJ; Wyss PA; Bickel MH
Xenobiotica; 1991 Jan; 21(1):111-20. PubMed ID: 2003362
[TBL] [Abstract][Full Text] [Related]
20. The contribution of lysosomal trapping in the uptake of desipramine and chloroquine by different tissues.
Daniel WA; Bickel MH; Honegger UE
Pharmacol Toxicol; 1995 Dec; 77(6):402-6. PubMed ID: 8835367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
